The IASLC is collecting member and patient experiences with COVID-19 as a way to pool knowledge and connect our members during this public health crisis. These stories, information from the Journal of Thoracic Oncology (JTO), and official statements from the IASLC will be published on this page. In addition, this page will feature links to important resources such as journal articles and social media groups relevant to the care of patients with lung cancer.

If you would like to share a video or written statement about your personal interactions, concerns, guidance and hopes, please send your submission via email to COVID19@iaslc.org. Instructions about how to transfer video files will be supplied as requested.

With so many uncertainties regarding resources and the unknown aspects of how COVID affects patients with lung cancer, IASLC members offer perspectives on some of the most timely questions about daily practice.

Pertinent Questions Regarding the Care of Patients with Lung Cancer in the COVID-19 Environment

Member Story: Dr. Noemi Reguart

Dr. Noemi Reguart is a medical oncologist at the Hospital Clínic in Barcelona, Spain. In Spain, these past few weeks have been difficult—especially for health...

Member Story: Suraj Samtani Bassarmal

Dr. Suraj Samtani is a medical oncologist living and working in Santiago, Chile. I'm a medical oncologist and I also work in an intensive...

Member Story: Dr. Shengxiang Ren

Dr. Shengxiang Ren is an associate professor at Shanghai Pulmonary Hospital, Tongji University and Vice Director at Shanghai Pulmonary Hospital. He is a vice...

Impact of COVID-19 on the Diagnostic Workup of Lung Cancer

The COVID-19 pandemic has created numerous challenges with the management of lung cancer, not the least of which is the initial diagnosis. The computer...

Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic

IASLC faculty members from Europe, Asia and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced-stage lung cancer during...

Impact of COVID-19 on Treatment of Lung Cancer Patients with Local...

This webinar, "Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease," will be presented by IASLC surgical and radiation...

Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic:...

This webinar will give a summary of recently published ESTRO & ASTRO practice guidelines about radiotherapy for lung cancer in the COVID-19 pandemic, whether radiotherapy...

In the newest episode of Lung Cancer Considered, the IASLC’s official podcast program, Dr. Shu-Yuan Xiao discusses an original research report in the Journal of Thoracic Oncology about the pathology of two patients from Wuhan with COVID-19 who were originally treated for lung cancer. Listen now.

Listen to Janet Freeman-Daily—writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat)—lead a discussion on the impact of the COVID-19 epidemic on lung cancer patients and healthcare providers. Janet is joined by Dr. Amy Moore, Director of Science and Research at the Go2 Foundation, Dr. Upal Basu Roy, Vice President of Research at LUNGevity Foundation, and Dr. Lecia Sequist, Director of Center for Innovation and Early Cancer Detection at Massachusetts General Hospital and the Landry Family Associate Professor of Medicine at Harvard Medical School.

Please find the most recent content published and in-press on the Coronavirus Disease 2019 (COVID-19) in our Journal of Thoracic Oncology. This collection of links will be updated as we add new articles and information. The full collection, including articles in pre-press, can also be found at JTO.org.

Short Communication: Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People’s Republic of China (published April 11, 2020)

Correspondence: Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019 (published April 11, 2020)

Correspondence: Coronavirus Disease 2019 or Lung Cancer: What Should We Treat? (published April 10, 2020)

Full-Length Article: A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab (published March 31, 2020)

Full-Length Article: 18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging (published March 31, 2020)

Correspondence: Exuberant Plasmocytosis in Bronchoalveolar Lavage Specimen of the First Patient Requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe (published March 17, 2020)


Short Communication: Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer (published February 27, 2020)

Correspondence: The Treatment and Outcome of a Lung Cancer Patient Infected with SARS-CoV-2 (published March 5, 2020)

Editorial: Coronaviruses: Facts, Myths and Hypotheses (published March 6, 2020)

Treatment guidance for lung cancer patients during the COVID-19 pandemic (published May 15, 2020)

A CALL FOR RAPID SUBMISSION OF DATA FOR AGGREGATE REVIEW: Can daily radiotherapy imaging be used a a potential screen for COVID-19? (published April 14, 2020)

Full-Length Article: Early Appearance of Coronavirus Disease 2019 Associated Pulmonary Infiltrates During Daily Radiotherapy Imaging for Lung Cancer (published April 11)

COVID-19 AND CANCER

It is not easy to find a cohesive collection of relevant journal articles and rapidly changing guidelines about COVID-19 in relation to patients with cancer. Erin M. Bange, MD, is a first-year oncology fellow at Penn Medicine, a diverse clinical and research entity of the University of Pennsylvania. Dr. Bange has assembled oncology-specific information into a helpful document, which IASLC will be posting as updated every few days.

View the PDF Supplemental Information Quick Reference